Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now?
- PMID: 31182257
- DOI: 10.1016/j.bmc.2019.05.038
Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now?
Erratum in
-
Erratum to "Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now?" [Bioorg. Med. Chem. 27 (2019) 3005-3060].Bioorg Med Chem. 2019 Nov 1;27(21):115072. doi: 10.1016/j.bmc.2019.115072. Epub 2019 Sep 16. Bioorg Med Chem. 2019. PMID: 31537435 No abstract available.
Abstract
Fluoroquinolones are considered one of the widely utilized antibiotics, specifically, with the recent development of newer generations such as moxifloxacin, delafloxacin and finafloxacin which possess a wider spectrum of activity and improved bioavailability. However, alarming increase in bacterial resistance reports worldwide incites medicinal chemists to employ guided-biologically-oriented-synthesis-strategies toward the modulation of quinolones derivatives activity. At present, quinolone scaffold diverse biological activities prompted the fortuitous discovery of novel antimicrobial and anticancer derivatives. Herein, the opponent arguments (2013-2015) regarding the structure activity relationships of fluoroquinolones' antibacterial, anticancer, antifungal activities are inscribed.
Keywords: Anticancer; Antimycobacterial; Bacterial resistance; Ciprofloxacin; Fluoroquinolones; Hybrid.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources